189
Views
66
CrossRef citations to date
0
Altmetric
Research Article

The Role of Surveillance CT Scans in Patients with Diffuse Large B-cell Non-Hodgkin's Lymphoma

, , &
Pages 123-125 | Published online: 01 Jul 2009

  • Armitage, J.O. (1993) "Treatment of non-Hodgkin's lymphoma", N. Engl. J. Med. 328(14), 1023-1030.
  • Philip, T., Gugliemi, C., Hagenbeek, A., Somers, R., Van der, L.H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. and Harousseau, J.L. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", N. Engl. J. Med. 333(23), 1540-1545.
  • Petersen, F.B., Appelbaum, F.R., Hill, R., Fisher, L.D., Bigelow, C.L., Sanders, J.E., Sullivan, K.M., Bensinger, W.I., Witherspoon, R.P. and Storb, R. (1990) "Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle", J. Clin. Oncol. 8(4), 638-647.
  • Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, Jr., C.A. and Miller, T.P. (1993) "Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", N. Engl. J. Med. 328(14), 1002-1006.
  • Kaplan, E.L. and Meier, P. (1958) "Non-parametric estimation from incomplete observations", J. Am. Star. Assoc. 53, 457-481.
  • Shipp, M.A. (1994) "Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?", Blood 83(5), 1165-1173.
  • Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., Hagenbeek, A., Somers, R., Chauvin, F. and Philip, T. (1998) "The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group", Blood 92(10), 3562-3568.
  • Weeks, J.C., Yeap, B.Y., Canellas, G.P. and Shipp, M.A. (1991) "Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission". J. Clin. Oncol 9(7), 1196-1203.
  • Radford, J.A., Eardley, A., Woodman, C. and Crowther, D. (1997) "Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records", BMJ 314(7077), 343-346.
  • Elis, A., Blickstein, D., Klein, O., Eliav-Ronen, R., Manor, Y. and Lishner, M. (2002) "Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies", Am. J. Hematol. 69(1), 41-44.
  • Jerusalem, G., Beguin, Y., Fassotte, M.F., Najjar, F., Paulus, P., Rigo, P. and Fillet, G. (1999) "Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging", Blood 94(2), 429-433.
  • Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., Wolf-Peeters, C., Mortelmans, L. and Verhoef, G. (2001) "Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?", J. Clin. Oncol. 19(2), 414-419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.